Product ID: UCMIG35B2172
Report ID:
UCMIG35B2172 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.
The global market for Point-of-Care Testing (POCT) was estimated to be valued at US$ XX Mn in 2021.
The global Point-of-Care Testing (POCT) Market is estimated to grow at a CAGR of XX% by 2028.
The global Point-of-Care Testing (POCT) Market is segmented on the basis of Product Type, Platform, Mode of Purchase, Testing Type, End-User, Geography.
Based on region, the global Point-of-Care Testing (POCT) Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the global Point-of-Care Testing (POCT) Market are , Sinocare Inc , Hoffmann La Roche Ltd , Siemens AG , Abott Laboratories , bioMrieux SA , Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC , Mankind pharma , OraSure Technologies, inc , A. Menarini Diagnostics s.r.l , ACON Laboratories , Trinity Biotech plc.
Product ID: UCMIG35B2172